Genetic disorders and gene therapy Gene therapy has transformed the concept of treatment for a genetic disorder, thus giving hopes to millions across the globe. Therefore, regarding biomedical resear...
FDA approval The U.S. Food and Drug Administration has granted Lenmeldy (atidarsagene autotemcel) approval. The FDA has approved this gene therapy as the first of its kind for the treatment of childr...
FDA approval of gene therapy The FDA has made it possible for people 12 years of age and older who have transfusion-dependent beta-thalassemia (TDT) to use exagamglogene autotemcel (Casgevy, Vertex)....
Gene Therapy Applied to Thalassemia: An Overview Thalassemia is one such blood disorder characterized by the body being unable to produce enough hemoglobin, making life unusually challenging for both...
Gene Therapy for Sickle Cell Anemia: An Introduction Gene therapy for sickle cell anemia has been one of the most promising methodologies in the treatment of this genetic disorder. This article takes...
Neurological diseases are big problems around the world because they cause a lot of death and disability. Traditional treatments haven't always worked, which has led to a change toward new methods l...
March 2024: Stem cell therapy has emerged as a promising treatment option for diabetes mellitus, potentially addressing the obstacles that patients encounter. Research in this field has investigated...
SHANGHAI, CHINA, October 10, 2022 - JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing, and commercializing cell immunotherapy p...